inalimarev
Biologicalexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2005 (NCT00103142)
Timeline
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- inalimarev
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00669734 | Phase 1 | Feb 1, 2010 | National Cancer Institute (NCI), Rutgers University |
| NCT00103142 | Phase 2 | Feb 1, 2005 | Duke University, National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 1 | 2 | 2005 |
| Duke University | Academic/Hospital | 1 | 1 | 1 | 2005 |
| Rutgers University | Academic/Hospital | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1